Home›Search›Therapeutic Advances in Rare Disease

Therapeutic Advances in Rare Disease

SAGE Publications Ltd · United Kingdom · Est. 2020

ISSN2633-0040eISSN2633-0040

SJR Q3✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS ESCI56

✓ Corroboration (3 more)+18

Total74

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 75% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.503

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.946

Total Worksi

131

Total Citationsi

633

2yr Mean Citednessi

1.74

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Medicine, General & Internal; Internal Medicine.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published2020

FrequencyAnnual

StatusActive (last: 2026)

Total Publications131

Publisher OrgSAGE Publishing

OA Since2019

Visit Journal Website

Submission Info

APC Cost💎 Diamond OA — Free

Peer ReviewSingle-blind

Review Time~15 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

SAGE Publications Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2633-0040 / 2633-0040

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

No APC (Free)

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

112

2020

161

2021

115

2022

135

2023

122

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Internal MedicineQ3

Subject Classification

Web of Science Categories

Medicine, General & Internal

Scopus Categories

Internal Medicine

Research Topics (OpenAlex)

Genomics and Rare DiseasesLysosomal Storage Disorders ResearchGenetics and Neurodevelopmental DisordersHealth Systems, Economic Evaluations, Quality of LifeMetabolism and Genetic DisordersMitochondrial Function and PathologyNeurogenetic and Muscular Disorders ResearchGlycogen Storage Diseases and MyoclonusGenetic Neurodegenerative DiseasesCellular transport and secretion

Frequently asked questions about Therapeutic Advances in Rare Disease

Is Therapeutic Advances in Rare Disease a predatory journal?

PubScope has no integrity flags on record for Therapeutic Advances in Rare Disease: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 74/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Therapeutic Advances in Rare Disease?

Therapeutic Advances in Rare Disease is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.74.

Is Therapeutic Advances in Rare Disease indexed in Scopus and Web of Science?

Therapeutic Advances in Rare Disease is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Therapeutic Advances in Rare Disease?